Form 8-K - Current report:
SEC Accession No. 0001206774-22-001546
Filing Date
2022-06-15
Accepted
2022-06-15 17:15:32
Documents
12
Period of Report
2022-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron4073661-8k.htm   iXBRL 8-K 26969
  Complete submission text file 0001206774-22-001546.txt   199494

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gern-20220609.xsd EX-101.SCH 2950
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20220609_pre.xml EX-101.PRE 22353
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20220609_lab.xml EX-101.LAB 34240
6 EXTRACTED XBRL INSTANCE DOCUMENT geron4073661-8k_htm.xml XML 3594
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 221018540
SIC: 2834 Pharmaceutical Preparations